Infectious Disease Molecular Diagnostics Global Market Report 2026

Description

Infectious disease molecular diagnostics involves advanced laboratory methods used to detect and identify genetic material from pathogens like bacteria, viruses, fungi, or parasites in patient samples. These diagnostics facilitate rapid and precise diagnosis of infectious diseases, enabling timely treatment and effective disease management.

The primary product categories in infectious disease molecular diagnostics include kits and reagents, instruments, software, and services. Kits and reagents consist of pre-packaged chemical and biological components designed for specific laboratory tests or procedures, such as detecting, measuring, or amplifying genetic material, proteins, or pathogens. Key technologies employed in this area include polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification, chips and microarrays, mass spectrometry, transcription-mediated amplification, among others. These tools are applied to a variety of conditions, including respiratory diseases, tuberculosis, meningitis, gastrointestinal infections, human papillomavirus, sexually transmitted infections, sepsis, and drug-resistant diseases. End users include hospitals and clinical laboratories, diagnostic labs, pharmaceutical companies, and academic and research institutions.

Tariffs are impacting the infectious disease molecular diagnostics market by increasing the cost of imported instruments, kits, and reagents, particularly impacting regions such as north america and europe where reliance on imported high-precision equipment is significant. The polymerase chain reaction and next-generation sequencing segments are most affected due to their high import content. While tariffs may slightly slow adoption in price-sensitive markets, they have also encouraged local manufacturing and innovation in diagnostic platforms, creating opportunities for domestic suppliers to capture market share.

The infectious disease molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease molecular diagnostics market statistics, including infectious disease molecular diagnostics industry global market size, regional shares, competitors with a infectious disease molecular diagnostics market share, detailed infectious disease molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease molecular diagnostics industry. This infectious disease molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease molecular diagnostics market size has grown strongly in recent years. It will grow from $30.46 billion in 2025 to $32.04 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to growing prevalence of infectious diseases, advancements in pcr and sequencing technologies, rising government funding for infectious disease research, increasing awareness about early diagnosis, expansion of clinical laboratories.

The infectious disease molecular diagnostics market size is expected to see steady growth in the next few years. It will grow to $38.77 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to growing adoption of ai-driven diagnostic tools, rise in demand for rapid and accurate diagnostics, expansion of emerging markets healthcare infrastructure, increasing focus on personalized medicine, growth of home-based molecular diagnostic solutions. Major trends in the forecast period include rapid point-of-care diagnostic adoption, rising demand for multiplex testing, integration of molecular diagnostics with ehr systems, expansion of infectious disease surveillance programs, increasing focus on antimicrobial resistance detection.

The rising incidence of infectious diseases is expected to drive the expansion of the infectious disease molecular diagnostics market in the coming years. Infectious diseases are conditions caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly from one individual to another. The growing prevalence of infectious diseases is largely attributed to globalization and increased travel, which allow pathogens to spread quickly across borders, turning localized outbreaks into global health crises. Infectious disease molecular diagnostics aid in managing these diseases by enabling rapid and accurate detection of pathogens at the genetic level, supporting early diagnosis, targeted therapy, and effective outbreak control. For example, in November 2024, the US Centers for Disease Control and Prevention (CDC), a US government agency, reported that tuberculosis (TB) cases in 2023 reached 9,633, up from 8,332 in 2022, representing a 15.6% rise in case numbers. Consequently, the growing prevalence of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.

Leading companies in the infectious disease molecular diagnostics market are concentrating on developing innovative solutions such as real-time polymerase chain reaction (PCR) kits, which enable rapid, accurate, and high-throughput detection of infectious pathogens. Real-time PCR kits amplify and detect specific genetic material of pathogens simultaneously in real time, allowing for fast and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, introduced Applied Biosystems TaqPath PCR kits for infectious disease detection in India. These kits offer fast, highly sensitive multiplex diagnostic solutions that perform real-time PCR detection of infectious disease targets through a complete workflow-from ribonucleic acid extraction to diagnostic report generation, typically within four hours. The kits include multiplexed assays targeting multiple pathogen genomic regions, internal process controls, and automated data interpretation, which reduces user error and improves reliability of results.

In May 2024, Bruker Corporation, a US-based scientific instrument and analytical technology company, acquired ELITechGroup for $0.94 billion. Through this acquisition, Bruker Corporation aims to enhance its expertise in infectious disease diagnostics by obtaining access to advanced sample-to-answer molecular diagnostic systems and an extensive portfolio of infectious disease assays that complement its existing products. ELITechGroup SAS is a France-based company specializing in infectious disease molecular diagnostics.

Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The infectious disease molecular diagnostics market consists of revenues earned by entities by providing services such as polymerase chain Reaction (PCR) testing, next-generation sequencing, isothermal nucleic acid amplification tests, point-of-care (POC) molecular testing, and viral load monitoring and resistance testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease molecular diagnostics market also includes sales of nucleic acid extraction systems, isothermal amplification assays, multiplex diagnostic panels, molecular diagnostic reagents and consumables, and bloodborne pathogen detection kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses infectious disease molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Type: Kits And Reagents; Instruments; Software And Services
2) By Technology: Polymerase Chain Reaction; In Situ Hybridization; Isothermal Nucleic Acid Amplification Technology; Chips And Microarrays; Sequencing-Based Molecular Diagnostics; Transcription Mediated Amplification; Other Technologies
3) By Application: Respiratory Diseases; Tuberculosis; Meningitis; Gastrointestinal Tract Infections; Human Papillomavirus; Sexually Transmitted Infections; Sepsis; Drug Resistance Diseases; Other Applications
4) By End-User: Hospitals And Clinical Laboratories; Diagnostic Laboratories; Pharmaceutical Companies; Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Isothermal Amplification Kits; Probe-Based Detection Reagents; Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems; Isothermal Amplification Instruments; Automated Sample Preparation Systems; Next-Generation Sequencing Platforms; Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information Management Systems; Cloud-Based Infectious Disease Diagnostic Platforms; Instrument Integration And Workflow Management Tools; Bioinformatics Services
Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company (BD); Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; Biomerieux S.A.; Quidel-Ortho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin S.p.A.; Seegene Inc.; Oxford Nanopore Technologies plc; Biocartis NV; T2 Biosystems Inc.; Sherlock Biosciences Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME4MIDMD01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Infectious Disease Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Infectious Disease Molecular Diagnostics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Infectious Disease Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Infectious Disease Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Biotechnology, Genomics & Precision Medicine
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Rapid Point-Of-Care Diagnostic Adoption
- 4.2.2 Rising Demand For Multiplex Testing
- 4.2.3 Integration Of Molecular Diagnostics With Ehr Systems
- 4.2.4 Expansion Of Infectious Disease Surveillance Programs
- 4.2.5 Increasing Focus On Antimicrobial Resistance Detection

5. Infectious Disease Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinical Laboratories
5.2 Diagnostic Laboratories
5.3 Pharmaceutical Companies
5.4 Academic And Research Institutes
5.5 Public Health Organizations

6. Infectious Disease Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Infectious Disease Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Infectious Disease Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Infectious Disease Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Infectious Disease Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease Molecular Diagnostics Market Segmentation

9.1. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Kits And Reagents, Instruments, Software And Services
9.2. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies
9.3. Global Infectious Disease Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
9.4. Global Infectious Disease Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
9.5. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
9.6. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
9.7. Global Infectious Disease Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services

10. Infectious Disease Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Infectious Disease Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Infectious Disease Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease Molecular Diagnostics Market

11.1. Asia-Pacific Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease Molecular Diagnostics Market

12.1. China Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease Molecular Diagnostics Market

13.1. India Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease Molecular Diagnostics Market

14.1. Japan Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease Molecular Diagnostics Market

15.1. Australia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease Molecular Diagnostics Market

16.1. Indonesia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease Molecular Diagnostics Market

17.1. South Korea Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease Molecular Diagnostics Market

18.1. Taiwan Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease Molecular Diagnostics Market

19.1. South East Asia Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease Molecular Diagnostics Market

20.1. Western Europe Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease Molecular Diagnostics Market

21.1. UK Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease Molecular Diagnostics Market

22.1. Germany Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease Molecular Diagnostics Market

23.1. France Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease Molecular Diagnostics Market

24.1. Italy Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease Molecular Diagnostics Market

25.1. Spain Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease Molecular Diagnostics Market

26.1. Eastern Europe Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease Molecular Diagnostics Market

27.1. Russia Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease Molecular Diagnostics Market

28.1. North America Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease Molecular Diagnostics Market

29.1. USA Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease Molecular Diagnostics Market

30.1. Canada Infectious Disease Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease Molecular Diagnostics Market

31.1. South America Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease Molecular Diagnostics Market

32.1. Brazil Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease Molecular Diagnostics Market

33.1. Middle East Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease Molecular Diagnostics Market

34.1. Africa Infectious Disease Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Infectious Disease Molecular Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease Molecular Diagnostics Market Regulatory and Investment Landscape

36. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Infectious Disease Molecular Diagnostics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Infectious Disease Molecular Diagnostics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Infectious Disease Molecular Diagnostics Market Company Profiles
- 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease Molecular Diagnostics Market Other Major And Innovative Companies

Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.

38. Global Infectious Disease Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease Molecular Diagnostics Market

40. Infectious Disease Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Infectious Disease Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
40.2 Infectious Disease Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
40.3 Infectious Disease Molecular Diagnostics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer